Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Nitazoxanide plus PEG-IFN/RBV beneficial in HCV genotype 1

April 26, 2010

PREEMPT trials show benefit of Botox in chronic migraine

April 26, 2010

Tanezumab shows benefit in patients with interstitial cystitis

April 23, 2010

Tacrolimus improves symptoms of bladder pain syndrome/interstitial cystitis

April 23, 2010

Nerviano Medical Sciences discovers new B-raf inhibitors for cancer therapy

April 23, 2010

BAL-30072 active against beta-lactamase-producing enterobacteria in vivo

April 23, 2010

Cempra presents preclinical and clinical phase I data on CEM-101 antibiotic

April 23, 2010

Clinical data support safety and efficacy of BI-207127 plus PEG-IFN/RBV in HCV genotype 1

April 23, 2010

Pfizer describes new oxazolidinone antibacterial

April 22, 2010

Cheminpharma presents preclinical data on new MEK 1 inhibitor

April 22, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...